Assurient uses a proprietary algorithm to analyze data captured with wearable monitors that can anticipate the exacerbation of a chronic disease. Conditions such as COPD (emphysema) and CHF (congestive heart failure) leave a subtle but identifiable biometric footprint as disease activity increases. The early identification of these patients will allow for earlier intervention with a resulting morbidity as well as substantial economic benefit. Assurient leverages these observations to predict and prevent admissions.